Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (Review)

By    

Molecular Medicine Reports, Vol. 11, Iss. 5, 2015-01 ,pp. : 3212-3218

Spandidos Publications

Access to resources Recommend Favorite

Induction of retinol-binding protein 4 and placenta-specific 8 expression in human prostate cancer cells remaining in bone following osteolytic tumor growth inhibition by osteoprotegerin

By      

International Journal of Oncology, Vol. 43, Iss. 2, 2013-01 ,pp. : 365-374

Spandidos Publications

Access to resources Recommend Favorite

Protective effects of the Tougu Xiaotong capsule on morphology and osteoprotegerin/nuclear factor-κB ligand expression in rabbits with knee osteoarthritis

By                      

Molecular Medicine Reports, Vol. 13, Iss. 1, 2016-01 ,pp. : 419-425

Spandidos Publications

Access to resources Recommend Favorite

Effect of gallium nitrate on the expression of osteoprotegerin and receptor activator of nuclear factorκB ligand in osteoblasts in vivo and in vitro

By          

Molecular Medicine Reports, Vol. 13, Iss. 1, 2016-01 ,pp. : 769-777

Spandidos Publications

Access to resources Recommend Favorite

Clinical and tumor significance of tropomyosin-1 expression levels in renal cell carcinoma

By  

Oncology Reports, Vol. 33, Iss. 3, 2015-01 ,pp. : 1326-1334

Spandidos Publications

Access to resources Recommend Favorite